🔴 Precigen is trading 4.1% down today as oil prices and Treasury yields rise

Precigen is trading 4.1% down at $7.57 as broader market sentiment weakens.

• The Nasdaq Composite is down 1.05%, as investors respond to higher oil prices, inflation concerns, and rising Treasury yields.
• No new company-specific negative catalyst was identified on September 23, 2026.
• The most recent company news was positive: FDA platform technology designation for AdenoVerse, announced September 21, but it is not explaining today’s decline.